2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and…

Overview of attention for article published in Arthritis & Rheumatology, April 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 8 news outlets
policy: 1 policy source
twitter: 22 X users

patent: 1 patent
guideline: 7 clinical guideline sources

Readers on

mendeley: 126 Mendeley

So far, Altmetric has seen 13 news stories from 8 outlets.

Juvenile idiopathic arthritis: recognition, diagnosis and conventional pharmacological management

Pharmaceutical Journal, 30 Apr 2024

Juvenile idiopathic arthritis (JIA) is an autoimmune disease whereby the body’s immune system fails to distinguish between self…

Amjevita is a prescription injection used to treat various autoimmune conditions. Learn about cost, side effects, dosage, and more.

Medical News Today, 30 May 2023

The Food and Drug Administration (FDA) approves prescription drugs such as Amjevita to treat certain conditions.

Autoimmune arthritis: Types, symptoms, and treatment

Medical News Today, 02 Aug 2022

Autoimmune arthritis refers to arthritis types in which a person’s immune system attacks their body.

Updated 2019 ACR/AF Recommendations for Treating JIA Polyarthritis

MPR, 09 May 2019

Based on emerging new evidence and expert and patient consensus, a guideline development team organized by the American College…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 9 additional news stories.